Heba A. Hazzah

793 total citations
17 papers, 624 citations indexed

About

Heba A. Hazzah is a scholar working on Pharmaceutical Science, Periodontics and Molecular Medicine. According to data from OpenAlex, Heba A. Hazzah has authored 17 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmaceutical Science, 5 papers in Periodontics and 5 papers in Molecular Medicine. Recurrent topics in Heba A. Hazzah's work include Curcumin's Biomedical Applications (5 papers), Oral Health Pathology and Treatment (5 papers) and Advanced Drug Delivery Systems (4 papers). Heba A. Hazzah is often cited by papers focused on Curcumin's Biomedical Applications (5 papers), Oral Health Pathology and Treatment (5 papers) and Advanced Drug Delivery Systems (4 papers). Heba A. Hazzah collaborates with scholars based in Egypt, United States and Spain. Heba A. Hazzah's co-authors include Ossama Y. Abdallah, Maha M. A. Nasra, Ragwa M. Farid, Magda A. El-Massik, Noha S. El-Salamouni, Passent M.E. Gaafar, Ming Ming Wen, Wessam M. El-Refaie, Giovanni Tosi and Nashiru Billa and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Heba A. Hazzah

16 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heba A. Hazzah Egypt 12 277 141 125 106 89 17 624
Abeer Ahmed Kassem Egypt 12 384 1.4× 143 1.0× 147 1.2× 33 0.3× 64 0.7× 20 754
Maha M. A. Nasra Egypt 13 251 0.9× 115 0.8× 68 0.5× 31 0.3× 78 0.9× 18 526
Wessam M. El-Refaie Egypt 14 337 1.2× 209 1.5× 168 1.3× 78 0.7× 95 1.1× 24 900
Lyda Halbaut Spain 21 565 2.0× 177 1.3× 138 1.1× 80 0.8× 60 0.7× 51 1.1k
Cíntia Maria Saia Cereda Brazil 22 650 2.3× 200 1.4× 142 1.1× 110 1.0× 49 0.6× 39 1.1k
Ragwa M. Farid Egypt 19 717 2.6× 341 2.4× 284 2.3× 170 1.6× 128 1.4× 34 1.4k
Aránzazu Zarzuelo Castañeda Spain 13 331 1.2× 241 1.7× 181 1.4× 160 1.5× 71 0.8× 41 1.1k
Jéssica Mendes Nadal Brazil 14 118 0.4× 78 0.6× 76 0.6× 30 0.3× 33 0.4× 39 541
Roop Khar India 16 641 2.3× 225 1.6× 147 1.2× 36 0.3× 33 0.4× 22 1.2k
Gihan S. Labib Egypt 11 171 0.6× 116 0.8× 171 1.4× 24 0.2× 31 0.3× 18 612

Countries citing papers authored by Heba A. Hazzah

Since Specialization
Citations

This map shows the geographic impact of Heba A. Hazzah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba A. Hazzah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba A. Hazzah more than expected).

Fields of papers citing papers by Heba A. Hazzah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heba A. Hazzah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba A. Hazzah. The network helps show where Heba A. Hazzah may publish in the future.

Co-authorship network of co-authors of Heba A. Hazzah

This figure shows the co-authorship network connecting the top 25 collaborators of Heba A. Hazzah. A scholar is included among the top collaborators of Heba A. Hazzah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heba A. Hazzah. Heba A. Hazzah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hazzah, Heba A., et al.. (2025). Strontium decorated mebendazole alginate nano-platform for bone marrow active targeting for the treatment of bone metastasis. Journal of Drug Delivery Science and Technology. 113. 107317–107317.
2.
4.
Gaafar, Passent M.E., Noha S. El-Salamouni, Ragwa M. Farid, et al.. (2021). Pegylated liquisomes: A novel combined passive targeting nanoplatform of L-carnosine for breast cancer. International Journal of Pharmaceutics. 602. 120666–120666. 18 indexed citations
5.
Hazzah, Heba A., Calvin A. Omolo, Nikhil Agrawal, et al.. (2020). Novel formulation of antimicrobial peptides enhances antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA). Amino Acids. 52(10). 1439–1457. 34 indexed citations
6.
Farid, Ragwa M., Passent M.E. Gaafar, Heba A. Hazzah, Maged W. Helmy, & Ossama Y. Abdallah. (2020). Chemotherapeutic Potential of L-Carnosine From Stimuli-Responsive Magnetic Nanoparticles Against Breast Cancer Model. Nanomedicine. 15(9). 891–911. 25 indexed citations
7.
Elnaggar, Yosra S.R., et al.. (2019). Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate. International Journal of Pharmaceutics. 564. 410–425. 60 indexed citations
8.
Nasra, Maha M. A., et al.. (2019). Mesoporous silica nanoparticles, a safe option for silymarin delivery: preparation, characterization, and in vivo evaluation. Drug Delivery and Translational Research. 9(5). 968–979. 27 indexed citations
9.
Hazzah, Heba A., et al.. (2018). Diosmin Nanocrystal–Loaded Wafers for Treatment of Diabetic Ulcer: In Vitro and In Vivo Evaluation. Journal of Pharmaceutical Sciences. 108(5). 1857–1871. 30 indexed citations
10.
Sharma, Anamika, Sizwe J. Zamisa, Heba A. Hazzah, et al.. (2018). Exploiting the Thiobarbituric Acid Scaffold for Antibacterial Activity. ChemMedChem. 13(18). 1923–1930. 12 indexed citations
11.
Nasra, Maha M. A., et al.. (2017). Formulation, in-vitro characterization and clinical evaluation of curcumin in-situ gel for treatment of periodontitis. Drug Delivery. 24(1). 133–142. 98 indexed citations
12.
Wen, Ming Ming, Noha S. El-Salamouni, Wessam M. El-Refaie, et al.. (2016). Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges. Journal of Controlled Release. 245. 95–107. 156 indexed citations
13.
Hazzah, Heba A., et al.. (2015). Treatment of Premalignant Lesions: Curcumin a Promising Non-Surgical Option. 2(5). 1 indexed citations
14.
Hazzah, Heba A., et al.. (2015). Gelucire-Based Nanoparticles for Curcumin Targeting to Oral Mucosa: Preparation, Characterization, and Antimicrobial Activity Assessment. Journal of Pharmaceutical Sciences. 104(11). 3913–3924. 49 indexed citations
15.
16.
Hazzah, Heba A., Ragwa M. Farid, Maha M. A. Nasra, Magda A. El-Massik, & Ossama Y. Abdallah. (2015). Lyophilized sponges loaded with curcumin solid lipid nanoparticles for buccal delivery: Development and characterization. International Journal of Pharmaceutics. 492(1-2). 248–257. 74 indexed citations
17.
Hazzah, Heba A., Magda A. El-Massik, Ossama Y. Abdallah, & Hamdy Abdelkader. (2013). Preparation and characterization of controlled-release doxazosin mesylate pellets using a simple drug layering-aquacoating technique. Journal of Pharmaceutical Investigation. 43(4). 333–342. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026